[144] IBEX Ltd SEC Filing

Rhea-AI Filing Summary

Form 144 filed for IBEX Ltd (IBEX) reports a proposed sale of 844 shares of common stock valued at $32,494 with an approximate sale date of 09/16/2025 on NASDAQ. The shares were acquired by the seller as a stock grant from the issuer on 07/01/2025 (1,210 shares acquired in that grant). The filing also discloses a prior disposal by the same person of 366 shares on 08/26/2025 for gross proceeds of $10,660.39. The filer certifies they have no material nonpublic information about the issuer.

Positive

• Required disclosure provided: The filer submitted a Form 144 with details on shares, acquisition method, broker, and planned sale date.
• Securities acquired as stock grant: Acquisition source and date (07/01/2025) are explicitly disclosed, clarifying the basis for resale eligibility.
• Prior sale disclosed: A sale of 366 shares on 08/26/2025 with gross proceeds $10,660.39 is reported, demonstrating transparency about recent transactions.

Negative

• Insider selling activity: Proposed resale of 844 shares (and a prior sale of 366 shares) indicates ongoing insider disposals within a short period.
• Limited context: Filing contains transactional details only and does not provide information on the seller's identity beyond name/address fields being present or on the issuer's financial condition.

Insights

Securities Analyst

TL;DR: Insider plans to sell a small block of recently granted shares; transaction is routine but worth noting for short-term share supply.

The filing documents a proposed sale of 844 common shares acquired via a stock grant on 07/01/2025 and lists an approximate sale date of 09/16/2025 on NASDAQ. The aggregate market value is stated as $32,494. The same individual sold 366 shares on 08/26/2025 for $10,660.39. This is a standard Rule 144 notice enabling public resale by a person previously restricted from selling; the details provided are factual and limited to the mechanics and timing of the proposed sale.

Corporate Governance Expert

TL;DR: Disclosure shows compliance with Rule 144 requirements for resale of granted shares; no governance red flags in the filing itself.

The form identifies the securities as a stock grant from the issuer dated 07/01/2025 and includes the required representation that the seller lacks material nonpublic information. The document lists broker information and prior sales in the past three months (366 shares on 08/26/2025). The filing is procedural, fulfilling disclosure obligations for an insider or affiliated person planning to resell restricted shares.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
COMMON STOCK	GLOBAL SHARES FINANCIAL SERVICES INC 575 WASHINGTON BLVD FLOOR 9 JERSEY CITY DC 07310-1616	844	32494.00	13315077	09/16/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
COMMON	07/01/2025	STOCK GRANT	ISSUER			1210	07/01/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Christina Alice Trofimuk-O'Connor c/o IBEX LIMITED 1717 Pennsylvania Avenue NW, Suite 825 Washington DC 20006	COMMON	08/26/2025	366	10660.39

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does IBEX's Form 144 disclose about the planned share sale?

The form reports a proposed sale of 844 common shares with an aggregate market value of $32,494, expected to occur on 09/16/2025 on NASDAQ.

How and when were the 844 shares to be sold acquired?

The shares were acquired as a stock grant from the issuer on 07/01/2025; the filing shows 1,210 shares were acquired in that grant.

Did the filer sell any IBEX shares recently?

Yes. The filing discloses a sale of 366 shares on 08/26/2025 for gross proceeds of $10,660.39.

Where will the proposed sale be executed?

The proposed sale lists NASDAQ as the securities exchange and names the broker as Global Shares Financial Services Inc with an address provided in the filing.

Does the filer claim possession of material nonpublic information?

No. By signing the notice, the person represents they do not know any material adverse nonpublic information regarding the issuer.